From the Mayo Clinic School of Medicine; Mayo Clinic Graduate School of Biomedical Sciences; Department of Health Sciences Research, and Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
K.M. Wilton, BS, MD/PhD Student, Mayo Clinic School of Medicine, and Mayo Clinic Graduate School of Biomedical Sciences; E.L. Matteson, MD, MPH, Professor of Medicine, Department of Health Sciences Research, and Division of Rheumatology, Mayo Clinic; C.S. Crowson, MS, Associate Professor of Medicine, Department of Health Sciences Research, Mayo Clinic.
J Rheumatol. 2018 Jan;45(1):45-52. doi: 10.3899/jrheum.170460. Epub 2017 Aug 1.
To define the incidence of obstructive sleep apnea (OSA) in patients with rheumatoid arthritis (RA) and determine whether OSA diagnosis predicts future cardiovascular disease (CVD) and noncardiac vascular events.
Medical information pertaining to RA, OSA, CVD, and vascular diagnoses was extracted from a comprehensive medical record system for a geographically defined population of 813 patients previously diagnosed with RA and 813 age- and sex-matched comparator subjects.
The risk for OSA in persons with RA versus comparators was elevated, although not reaching statistical significance (HR 1.32, 95% CI 0.98-1.77; p = 0.07). Patients with RA were more likely to be diagnosed with OSA if they had traditional risk factors for OSA, including male sex, current smoking status, hypertension, diabetes, dyslipidemia, and increased body mass index. Features of RA disease associated with OSA included large joint swelling and joint surgery. Patients with RA with decreased renal function were also at higher risk of OSA. The increased risk of overall CVD among patients with RA who have OSA was similar to the increased CVD risk associated with OSA in the comparator cohort (interaction p = 0.86). OSA diagnosis was associated with an increased risk of both CVD (HR 1.9, 95% CI 1.08-3.27), and cerebrovascular disease (HR 2.4, 95% CI 1.14-5.26) in patients with RA.
Patients with RA may be at increased risk of OSA secondary to both traditional and RA-related risk factors. Diagnosis with OSA predicts future CVD in RA and may provide an opportunity for CVD intervention.
确定类风湿关节炎(RA)患者阻塞性睡眠呼吸暂停(OSA)的发病率,并确定 OSA 诊断是否预测未来的心血管疾病(CVD)和非心血管事件。
从先前诊断为 RA 的 813 名患者和年龄及性别匹配的 813 名对照者的综合病历系统中提取与 RA、OSA、CVD 和血管诊断相关的医学信息。
RA 患者发生 OSA 的风险高于对照者,但未达到统计学意义(HR 1.32,95%CI 0.98-1.77;p = 0.07)。如果 RA 患者具有 OSA 的传统危险因素,包括男性、当前吸烟状况、高血压、糖尿病、血脂异常和体重指数增加,则更有可能被诊断为 OSA。与 OSA 相关的 RA 疾病特征包括大关节肿胀和关节手术。肾功能下降的 RA 患者发生 OSA 的风险也更高。RA 合并 OSA 的患者发生总体 CVD 的风险增加与对照者中 OSA 相关的 CVD 风险增加相似(交互作用 p = 0.86)。OSA 诊断与 RA 患者 CVD(HR 1.9,95%CI 1.08-3.27)和脑血管疾病(HR 2.4,95%CI 1.14-5.26)的风险增加相关。
RA 患者可能由于传统和 RA 相关的危险因素而面临 OSA 的风险增加。OSA 诊断可预测 RA 患者未来的 CVD,并可能为 CVD 干预提供机会。